Intensive Care Anxiety in SARS-CoV-2 Patients
1 other identifier
observational
100
1 country
1
Brief Summary
It should be known by the clinician that COVID-19 patients are prone to anxiety, and these disorders need to be properly diagnosed and addressed to improve prognosis, shorten hospital stay and avoid long-term mental health problems.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 15, 2021
CompletedStudy Start
First participant enrolled
January 17, 2021
CompletedFirst Posted
Study publicly available on registry
January 20, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 15, 2021
CompletedJanuary 20, 2021
January 1, 2021
2 months
January 15, 2021
January 16, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
intensive care Anxiety
Hospital Anxiety Depression scale
3 month
Study Arms (1)
Hospital Anxiety Depression Measure
Hospital Anxiety Depression Measure
Interventions
Hospital Anxiety Depression Measure
Eligibility Criteria
Co-operative patients over 18 years of age, with COVID PCR + admission to intensive care unit, will be included in the study.
You may qualify if:
- Above 18 years old
- COVID PCR +,
- admitted to intensive care,
- conscious, cooperative patients
You may not qualify if:
- Having hearing and speaking problems,
- Can't speak Turkish or English,
- who do not have the cognitive level to understand and answer the questions,
- Communication problems such as dementia and Alzheimer's,
- patients receiving sedation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
İlke Küpeli
İzmit, Kocaeli̇, Turkey (Türkiye)
Related Publications (4)
Deng J, Zhou F, Hou W, Silver Z, Wong CY, Chang O, Huang E, Zuo QK. The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: a meta-analysis. Ann N Y Acad Sci. 2021 Feb;1486(1):90-111. doi: 10.1111/nyas.14506. Epub 2020 Oct 2.
PMID: 33009668RESULTRogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, Zandi MS, Lewis G, David AS. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020 Jul;7(7):611-627. doi: 10.1016/S2215-0366(20)30203-0. Epub 2020 May 18.
PMID: 32437679RESULT3. Aydemir Ö, Güvenir T, Küey L, Kültür S. Hastane Anksiyete ve Depresyon Ölçeği Türkçe Formunun Geçerlik Güvenilirlik Çalışması. Türk Psikiyatri Dergisi 1997;8:280-287.
RESULTKupeli I, Kara MY, Yakin I, Caglayan AC. Anxiety and depression in the first 24 h in COVID-19 patients who underwent non-invasive mechanical ventilation in the intensive care unit. Ir J Med Sci. 2022 Oct;191(5):2291-2295. doi: 10.1007/s11845-021-02808-8. Epub 2021 Oct 19.
PMID: 34664224DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
ilke kupeli
Derince Training and Research Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- assoc. prof.
Study Record Dates
First Submitted
January 15, 2021
First Posted
January 20, 2021
Study Start
January 17, 2021
Primary Completion
April 1, 2021
Study Completion
April 15, 2021
Last Updated
January 20, 2021
Record last verified: 2021-01
Data Sharing
- IPD Sharing
- Will not share